Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Blue Harbour Boosts Babcock & Wilcox Co (BWC) Stake after Company Announces Spin-Off Plans

Clifton S. RobbinsBlue Harbour Group has surged its activist stake in Babcock & Wilcox Co (NYSE:BWC), as a new filing with the Securities and Exchange Commission showed. Blue Harbour reported ownership of approximately 9.14 million shares of the company, representing 8.6% of the common stock. Previously, the fund held around 7.03 million shares of Babcock & Wilcox, as it reported in its latest 13F filing.

Clifton Robbins Blue Harbour

Blue Harbour is an activist fund that was founded in 2004 by a former partner at private equity firm KKR, Clifton Robbins. The fund has an equity portfolio worth over $2.5 billion, which is relatively diversified and mainly consists of stocks from Technology, Services, and Basic Materials sectors. The fund has made some bullish moves over the last couple of months, such as raising its exposure to Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to 12.64 million shares, equal to 7% of the common stock. The investor has also been increasing its position in Rowan Companies PLC (NYSE:RDC), of which it owns 9.78 million class A shares, representing 7.9% of the class.

Blue Harbour Group has been bullish on Babcock & Wilcox Co (NYSE:BWC) since the end of 2013. The fund initiated a stake during the fourth quarter of 2013, reporting ownership of approximately 1.10 million shares. During the first quarter, the stake was surged to 5.21 million shares and during the April-June, the investor raised its stake further to 7.03 million shares, the position amassing 8.84% of the equity portfolio, which was the second-largest stake in terms of value. Babcock & Wilcox lost around 11% since the beginning of the year.

Among the funds that we track, Blue Harbour is currently the largest shareholder of Babcock & Wilcox Co (NYSE:BWC). Moreover, many other great investors have also been bullish on the company. Jeffrey Smith‘s Starboard Value LP reported ownership of around 3.68 million shares in its latest 13F filing, up by 84% on the quarter. Israel Englander‘s Millennium Management raised its position by 145% during the second quarter to 853,900 shares. On the other hand, Larry Robbins‘ Glenview Capital cut its stake by 36% to 3.54 million shares. David Einhorn‘s Greenlight Capital reduced its position by 62% respectively 1.49 million shares, although the company is still one of his top picks among small-cap stocks.

However, Blue Harbour boosted its stake a day after the company announced its plan for a tax-free spin-off of its Power Generation business. The spin-off will result in the creation of two indepent publicly-traded companies, Babcock & Wilcox, which will comprise the Power Generation business and BWX Technologies that will focus on Government and Nuclear operations. Shareholders of the current Babcock & Wilcox Co (NYSE:BWC) will receive shares of the new Babcock & Wilcox by the middle of next year.

The impact of the spin-off is yet to be assessed by analysts and experts in the power generation business, but Blue Harbour’s ‘bullishness’ should also raise some flags for other investors. It often comes that spin-off companies become very successful and in some cases even manage to perform better than their former parent companies. In this way, tracking the activity of big investors can provide some insights to retail investors, because big funds usually invest large amounts of money and research thoroughly their next moves, which is why Babcock & Wilcox Co (NYSE:BWC) is a stock worth keeping on the radars.

Disclosure: none

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!